Ozempic, Mounjaro, Wegovy, Zepbound — GLP-1 receptor agonists have become the most sought-after medications in America. And with demand far outstripping supply, prices reaching $1,000–$1,500/month without insurance, and chronic shortages at US pharmacies, a new category of medical tourism is emerging: patients traveling abroad for access and affordability.
What GLP-1 Medications Cost in the US
| Medication | US List Price (monthly) | With Insurance (typical) | Without Insurance |
|---|---|---|---|
| Ozempic (semaglutide) | $935 | $25–$300 | $800–$1,000 |
| Wegovy (semaglutide) | $1,350 | $0–$500 | $1,200–$1,400 |
| Mounjaro (tirzepatide) | $1,023 | $25–$300 | $900–$1,100 |
| Zepbound (tirzepatide) | $1,060 | $0–$500 | $1,000–$1,100 |
Even with insurance, prior authorization battles, step therapy requirements, and quantity limits make consistent access difficult. Many patients have coverage on paper but cannot actually fill their prescriptions reliably.
What Patients Are Doing Abroad
Three patterns have emerged:
Pattern 1: Filling prescriptions in Mexico. Semaglutide (the active ingredient in Ozempic/Wegovy) is available at Mexican pharmacies at roughly $200–$400/month. Some Americans cross the border regularly to fill prescriptions. This is legal for personal use in quantities consistent with a 90-day supply, though the FDA technically does not approve personal importation.
Pattern 2: Medically supervised weight management programs abroad. Clinics in Colombia, Mexico, and other countries offer comprehensive weight loss programs that include GLP-1 prescriptions as part of a supervised medical plan — physician evaluation, metabolic testing, nutritional counseling, and ongoing monitoring — at a fraction of US program costs.
Pattern 3: Combining GLP-1 treatment with bariatric evaluation. Some patients use an international medical consultation to determine whether GLP-1 medication or bariatric surgery is the better long-term approach, given that both are dramatically cheaper abroad.
The Safety Considerations
GLP-1 tourism carries specific risks that differ from surgical medical tourism:
- Counterfeit medications. The demand for semaglutide has created a market for counterfeit products. This is a real risk in unregulated pharmacy settings. Only obtain GLP-1 medications from licensed pharmacies with verifiable supply chains.
- Compounded semaglutide. Some clinics (domestic and international) offer "compounded" semaglutide — custom-mixed versions that are not FDA-approved and may not contain the same formulation as brand-name products. The safety and efficacy of compounded versions are not established.
- Medical supervision matters. GLP-1 medications have real side effects (nausea, pancreatitis risk, gallbladder issues, thyroid considerations) that require medical monitoring. Self-prescribing through an unregulated source is risky.
- Legal considerations. Importing prescription medications for personal use exists in a legal gray area. While enforcement is minimal for personal quantities, it is not formally legal.
If you are considering obtaining GLP-1 medications abroad, the safest approach is through a legitimate medical clinic with a licensed physician who evaluates you, prescribes appropriately, and monitors your response — not through a pharmacy visit without medical oversight.
The Bigger Picture
GLP-1 tourism is a symptom of the same structural problem driving all medical tourism: the US healthcare system prices essential treatments beyond the reach of the people who need them. When a medication that costs $200/month to produce is sold for $1,350/month, and the people who need it cannot get it, they will find alternatives.
Whether those alternatives are safe and well-supervised — or risky and unregulated — depends largely on the quality of information available to patients. That is why we publish guides like this one.
Need Guidance on Weight Management Options Abroad?
We can connect you with medically supervised programs that include proper evaluation, prescription, and monitoring.
Explore Options →